comparemela.com
2
3
4
5
6
7
8
Latest Breaking News On - Biostar pharma - Page 1 : comparemela.com
FDA Gives Brain Metastasis Drug Orphan Drug Designation
The Food and Drug Administration granted UTD1 an orphan drug designation to treat brain metastases in patients with breast cancer.
Biostar-pharma
Drug-administration
National-institutes-of-health
Biostar-pharmaceuticals
Unmet-need
National-institutes
Educated-patient
Breast-cancer-summit
News
Breast-cancer
Breast-cancer-brain-metastasis
Brain-metastasis
US FDA grants orphan drug designation to Biostar Pharma's utidelone
Biostar Pharma has announced that its pipeline product, UTD1, has received ODD from the US FDA for the treatment of breast cancer BCBM.
Biostar-pharma
UTD1 Receives FDA Orphan Drug Designation in Breast Cancer Brain Metastasis
Utidelone injectable has received FDA orphan drug designation for patients with breast cancer brain metastases.
Biostar-pharma
Biostar-pharma-inc
Response-assessment
Fda
Breast-cancer-brain-metastases
Fda-orphan-drug-designation
Utidelone-injectable
73% CNS ORR! FDA Granted ODD to Utidelone Injectable (UTD1) from Biostar Pharma for the Treatment of Breast Cancer Brain Metastasis
SAN FRANCISCO, March 29, 2024 /PRNewswire/ Biostar Pharma, Inc., the U.S. subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. which is a synthetic
Thailand
Biostar-pharma
Biostar-pharma-inc
Biostar-pharmaceuticals-co-ltd
Orphan-drug-designation
Thailand-business
Utidelone Injectable Granted FDA Orphan Drug Designation for Breast Cancer Brain Metastasis
The recent ODD for the utidelone injectable could offer another treatment option for patients with BCBM.
Biostar-pharma
Utidelone-injectable
Breast-cancer-brain
Metastatic-brain
Accessed-march
vimarsana © 2020. All Rights Reserved.